All Janssen has to do is make an extended release form in the right dose for improving lactation, and then submit it as a substantial improvement. Voila, new patent. US manufacturers do it all the time! Tegretol (carbamazepine- an anticonvulsant)--Tegretol XR (extended release carbamazepine through an indigestible tablet with a pinhole to let the drug out in controlled amounts)--Carbatrol (extended release carbamazepine by controlled dissolution) and finally Trileptal (oxcarbamazepine - adding that tiny group totally changes metabolism of the drug, avoiding the most problematic metabolite (carbamazepine epoxide) in terms of side effects, without reducing the effectiveness of the drug.) I certainly think it would be worth their money, or anyone else's. Catherine Watson Genna, BS, IBCLC NYC *********************************************** To temporarily stop your subscription: set lactnet nomail To start it again: set lactnet mail (or digest) To unsubscribe: unsubscribe lactnet All commands go to [log in to unmask] The LACTNET mailing list is powered by L-Soft's renowned LISTSERV(R) list management software together with L-Soft's LSMTP(R) mailer for lightning fast mail delivery. For more information, go to: http://www.lsoft.com/LISTSERV-powered.html